Smith W Bradford has filed 10 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 32000 shares of Lyra Therapeutics, Inc. ($LYRA) on May 14, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | Lyra Therapeutics, Inc. | $LYRA | Smith W Bradford | Not found | A | Restricted Stock Units | 32000 | $0.00 | 32,000.0000 | 65,880,561 | 9999.99% | 0.05% |
| June 13, 2024 | Lyra Therapeutics, Inc. | $LYRA | Smith W Bradford | Not found | A | Stock Option | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | Lyra Therapeutics, Inc. | $LYRA | Smith W Bradford | Not found | A | Stock Option | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Q32 Bio Inc. | $QTTB | Smith W Bradford | See remarks | A | Restricted Stock Units | 36000 | $0.00 | 36,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Q32 Bio Inc. | $QTTB | Smith W Bradford | See remarks | A | Employee Stock Option (Right to Buy) | 213000 | $0.00 | 213,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2023 | Q32 Bio Inc. | $QTTB | Smith W Bradford | See Remarks | S | Common Stock | 3729 | $1.39 | 14,219.0000 | 0 | 20.78% | 0.00% |
| Jan. 1, 2023 | Q32 Bio Inc. | $QTTB | Smith W Bradford | See Remarks | M | Restricted Stock Units | 6930 | $0.00 | 14,070.0000 | 0 | 33.00% | 0.00% |
| Jan. 1, 2023 | Q32 Bio Inc. | $QTTB | Smith W Bradford | See Remarks | M | Common Stock | 6930 | $0.00 | 17,948.0000 | 0 | 62.90% | 0.00% |
| Jan. 1, 2023 | Q32 Bio Inc. | $QTTB | Smith W Bradford | See Remarks | M | Common Stock | 6600 | $0.00 | 11,018.0000 | 0 | 149.39% | 0.00% |
| Jan. 1, 2023 | Q32 Bio Inc. | $QTTB | Smith W Bradford | See Remarks | M | Restricted Stock Units | 6600 | $0.00 | 6,800.0000 | 0 | 49.25% | 0.00% |